Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit
- Wednesday, June 1, 2022, 7:00
- Finance
- Add a comment
SHANGHAI, June 1, 2022 /PRNewswire/ — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) announced that it has received CE marking for its OverC™ Multi-Cancer Detection Blood Test manufactured in both the US and China facilities (Identification Number:…
About the Author
adminasapcorp has written 38945 stories on this site.